Delivery Order SPE2DP20D0002-SPE2DP21F2057
- Not listed
- The Defense Logistics Agency Troop Support Medical has awarded a firm fixed-price delivery order worth $458,090.64 to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This contract supports military immunization programs. Teva is an experienced federal contractor, having provided a variety of drug products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a $146,823.93 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. This order supports military immunization programs. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit organization that manufactures a range of drug products, including vaccines, antivirals, respiratory treatments, and multiple sclerosis medications for federal customers...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, a $476,414.19 firm-fixed-price delivery order to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime contracts by federal agencies such as the...
- The Defense Logistics Agency Troop Support Medical awarded a $141,176.88 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc. to supply Adenovirus Type 4 vaccine. This award is not associated with a set-aside program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has provided various drug products, including vaccines, antiviral medications, and respiratory treatments, to federal customers such as the Department of Defense and...
- The U.S. Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a pharmaceutical manufacturer, to supply Adenovirus Type 4 vaccine. The $282,353.76 contract has a completion date of January 26, 2021. Teva Pharmaceuticals is a foreign-owned, for-profit organization that provides a range of drug products to federal agencies, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs. The...
- The U.S. Defense Logistics Agency Troop Support Medical awarded Teva Pharmaceuticals USA, Inc. a $141,176.88 firm fixed-price delivery order to provide Adenovirus Type 4 vaccine. This order was not set aside under any special socioeconomic program. Teva Pharmaceuticals USA, Inc. is a foreign-owned, for-profit pharmaceutical manufacturer that has an extensive history of providing drug products, including vaccines and respiratory medications, to federal agencies such as the Department of Defense...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide adenovirus type 4 vaccine. The $146,823.93 order is not set aside and has a completion date of July 26, 2022. Teva has previously received numerous delivery orders from the Defense Logistics Agency to supply adenovirus vaccines and other pharmaceutical products such as albuterol inhalers to federal...
- Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer, was awarded a $135,747 delivery order by the Defense Logistics Agency (DLA) Troop Support Medical for the supply of Adenovirus Type 4 vaccine. The order has a completion date of September 29, 2020 and was issued under a firm-fixed price contract. Teva is an experienced provider of pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal agencies...
- The Defense Logistics Agency Troop Support Medical awarded a firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit manufacturer of pharmaceutical products, to provide Adenovirus Type 4 vaccine. The $135,747.00 order has an October 27, 2020 completion date and was awarded on October 19, 2020. Teva has received numerous awards from the Defense Logistics Agency and Department of Veterans Affairs to supply vaccines, antiviral medications, respiratory...
- The Defense Logistics Agency (DLA) Troop Support Medical awarded a $476,414.19 firm-fixed-price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned, for-profit pharmaceutical manufacturer, to provide Adenovirus Type 4 vaccine. The contract has a completion date of February 27, 2024 and does not utilize a set-aside designation. Teva Pharmaceuticals USA, Inc. is a subsidiary of the global pharmaceutical company Teva Pharmaceutical Industries Ltd. and has been awarded numerous prime...
- SPE2DP20D0002Indefinite Delivery Contract
- SPE2DP20D0002-SPE2DP21F2057Delivery Order
The Defense Logistics Agency Troop Support Medical awarded a $282,353.76 firm fixed price delivery order to Teva Pharmaceuticals USA, Inc., a foreign-owned for-profit pharmaceutical manufacturer, for the supply of Adenovirus Type 4 vaccine. This award is not associated with a set-aside contract. Teva Pharmaceuticals has a history of providing pharmaceutical products, including vaccines, antiviral medications, respiratory treatments, and multiple sclerosis drugs, to federal customers such as the Department of Defense and the Department of Veterans Affairs. The company also holds active indefinite delivery contracts to furnish a variety of drugs to agencies including the Defense Logistics Agency, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
ADENOVIRUS TYPE 4 A | SPE2DP18R01130009 | Defense Logistics Agency Troop Support Medical | Award Notice 1/1 | 2/3/20, 2:02 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $282.4k | 2/11/21 |